Solta Medical, Inc.
George S. Mack, The Life Sciences Report
Forget big medtech and find your growth plays in niche companies.
A decade ago medtech was in its heyday. Baby boomers were already feeling the discomforts of osteoarthritis and other age-related diseases, and they wanted to be active longer. Device and instrument developers could innovate and get products through the FDA and market them in the U.S. where dynamic pricing power would more »